NDC 70771-1325-02 - candesartan cilexetil and hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1325
- Requested NDC
- 70771-1325-02
- Package NDCs from labels
- 70771-1325-3, 70771-1325-9, 70771-1325-0, 70771-1325-1, 70771-1325-2, 70771-1325-4, 70771-1325-02
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-11-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| candesartan cilexetil and hydrochlorothiazide - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-11-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1325-0 | candesartan cilexetil and hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 5 | |
| 70771-1325-1 | candesartan cilexetil and hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 5 | |
| 70771-1325-2 | candesartan cilexetil and hydrochlorothiazide | 10 in 1 BLISTER PACK | TABLET | 10 | 5 | |
| 70771-1325-3 | candesartan cilexetil and hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 70771-1325-4 | candesartan cilexetil and hydrochlorothiazide | 10 in 1 CARTON | TABLET | 10 | 5 | |
| 70771-1325-9 | candesartan cilexetil and hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1325 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLET [ZYDUS LIFESCIENCES LIMITED] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241113_cb328bc1-5738-4620-b2b3-442e98388a86.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2026-11-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2026-11-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 5f4e3bc8-2810-f1ae-e063-6394a90a9725 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | b2d444ee-588d-37a9-e053-2a95a90ad2f1 | 2026-10-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2026-10-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 89d367b1-de04-4970-9967-27a1c7711c0f | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 447c11b6-72fe-418e-a2db-5d90b5347796 | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 2106032d-5678-4c25-b8a7-f19ac2afafd4 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 24d40f18-b98c-48fc-8d97-5f3e351afc31 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | f20fd735-30c7-4f89-8ceb-b6186646eea6 | 2026-10-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 1fff8245-2b65-4ab1-aaa2-6bbbc6ac5fe8 | 2026-10-19 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.